Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment — BIOVRAIE

Plantar Warts Clinical Trial

Official title:
Evaluation of Viral Status of Patients With Plantar Warts Included in VRAIE Study, Non-responder to Study Treatment

Status Terminated

Clinical Trial Summary

The principal objective of the study is the evaluation of the role of Human Papilloma Virus (HPV) in plantar warts (prevalence, genotype), resistant or not, treated or not, cured or not. This epidemiological study is an ancillary study of the prospective, randomized controlled, clinical study VRAIE (sponsor: APHP) comparing 5 usual strategies in the management of plantar warts.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02861404
Study type	Observational
Source	Centre Hospitalier Universitaire de Besancon
Contact
Status	Terminated
Phase	N/A
Start date	April 2010
Completion date	June 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02338336` - A Phase I/II Double-blind Study to Evaluate the Safety and Efficacy of Nowarta110 in Patients With Plantar Warts Successfully Completed	Phase 1/Phase 2
Recruiting	`NCT01330615` - Efficacy Trial of Eutectic Lidocaine/Prilocaine Cream 5% (EMLA) for Analgesia Prior to Cryotherapy of Verrucae Plantaris	N/A
Terminated	`NCT01059110` - Comparison of Five Treatments in Patients With Plantar Warts	Phase 4
Active, not recruiting	`NCT02640820` - Evaluate the Effectiveness and Safety of DPCP Ointment (Samcyprone™) on the Clearance of Verruca Vulgaris (Common Warts)	Phase 2